The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

FDA Approves SIR-Spheres for Liver Most cancers Therapy

The FDA authorized SIR-Spheres Y-90 resin microspheres for unresectable liver most cancers, the one radioembolization authorized within the U.S. for each HCC and...

FDA Grants Orphan Drug Standing to MB-101 for Glioblastoma, Astrocytomas

The FDA granted orphan drug designation to a CAR T-cell remedy for recurrent glioblastoma and high-grade astrocytomas.The U.S. Meals and Drug Administration (FDA)...

Understanding the Threat of Overtreatment in Prostate Most cancers

It is very important goal intensified remedy to sufferers who're most certainly to profit, thereby avoiding pointless therapy and toxicity in sufferers who...

Empowering the Immune System

TIL remedy is on the rise in melanoma, with potential for different tumor varieties.Katie Ortman Doble was 31 years outdated when she was...

Rising from Embarrassment to Admiration of My Mom’s Breast Most cancers

Robyn Quesada displays on watching her mom’s breast most cancers battle from age 12, sharing classes of empathy, power, and household love over...

Hot Topics